Robert Hess is a highly experienced angel investor, with a passion for supporting innovative startups in the fields of Pharma/Biotech, Medtech, and B2B SaaS. With over 40 angel investments to his name, he is a valuable member of numerous organizations, including the Life Science Angels, Band of Angels, and Tech Coast Angels. Additionally, he serves as co-chair of the Device and Digital Health Committee of Life Science Angels, and holds a position as a Board Observer for Purissima, and Strategikon Pharma.

Hess brings a wealth of knowledge and experience to his investments, previously holding positions as a patent attorney prosecuting patents in biotechnology and medical devices. He has also served as the Vice President of Business Development at BioTrove, Inc., and Director of Research at BioSeq/BBI-BioSeq. Hess received a B.S. in Biochemistry from Cornell University, a Ph.D. in Molecular Biophysics from the University of Wisconsin-Madison, and a J.D. from Suffolk University Law School with a concentration in Intellectual Property.

Overall, Robert Hess is a prominent figure in the startup world, passionately supporting and investing in startups that can change the world.